In the fast-moving world of breast cancer immunotherapy, few biomarkers have generated as much enthusiasm as tumor-infiltrating lymphocytes, the immune cells that swarm into tumors and signal that the body’s own defenses are engaged against the disease. Now, a newly published correspondence in the journal Breast Cancer Research and Treatment is urging clinicians and researchers […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.